Condition: Organ Preservation · Rectal Cancer · Quality of Life · Sponsor: The Netherlands Cancer Institute
The goal of this prospective phase II feasibility study is to evaluate two additional local treatment options in rectal cancer patients with a good clinical response after neoadjuvant (chemo)radiation: contact x-ray brachytherapy versus extension of the waiting interval with or without local excision, and to investigate which rate of organ preservation can be achieved.
This description comes directly from the study's public registry record.
Barbara M Geubels, MD · 0205129001 · b.geubels@nki.nl
Brechtje A Grotenhuis, MD, PhD · 020 239 9111 · b.grotenhuis@nki.nl
Always discuss trial participation with your own doctor first.
| Radbouw University Medical Centre | Nijmegen, Gelderland, Netherlands | Recruiting |
| Catharina Hospital | Eindhoven, North Brabant, Netherlands | Recruiting |
| Antoni van Leeuwenhoek | Amsterdam, North Holland, Netherlands | Recruiting |
| Deventer Hospital | Deventer, Overijssel, Netherlands | Recruiting |
| Isala | Zwolle, Overijssel, Netherlands | Recruiting |
| Medical Center Leeuwarden | Leeuwarden, Provincie Friesland, Netherlands | Recruiting |
| Ijsselland Hospital | Capelle aan den IJssel, South Holland, Netherlands | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT05772923